{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:20:13Z","timestamp":1648966813473},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamadermatol.2018.5233","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T01:05:33Z","timestamp":1550711133000},"page":"483","source":"Crossref","is-referenced-by-count":0,"title":["Yellow Periorbital Plaque and Retroperitoneal Fibrosis"],"prefix":"10.1001","volume":"155","author":[{"given":"Jonathan A.","family":"Braue","sequence":"first","affiliation":[{"name":"Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami N.","family":"Al-Rohil","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"dcg180025r1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rdc.2013.02.011","article-title":"Erdheim-Chester disease.","volume":"39","author":"Haroche","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"dcg180025r2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study.","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv"},{"issue":"22","key":"dcg180025r3","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"3","key":"dcg180025r4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jaad.2015.11.007","article-title":"Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients.","volume":"74","author":"Chasset","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"dcg180025r5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2016-12-757823","article-title":"Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.","volume":"130","author":"Milne","year":"2017","journal-title":"Blood"},{"issue":"13","key":"dcg180025r6","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"1","key":"dcg180025r7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bjd.15306","article-title":"Paediatric Erdheim-Chester disease with aggressive skin manifestations.","volume":"178","author":"Su","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"dcg180025r8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/bjh.2018.180.issue-1","article-title":"Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.","volume":"180","author":"Cohen Aubart","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"dcg180025r9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41408-017-0034-7","article-title":"Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease.","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J"},{"issue":"11","key":"dcg180025r10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).","volume":"130","author":"Cohen Aubart","year":"2017","journal-title":"Blood"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamadermatology\/article-pdf\/155\/4\/483\/17478178\/jamadermatology_braue_2019_cg_180025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T15:06:47Z","timestamp":1554908807000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.5233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.5233","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}